Cargando…
Randomized Placebo‐Controlled Clinical Trial of a Chewable Formulation of Amlodipine for the Treatment of Hypertension in Client‐Owned Cats
BACKGROUND: There is an unmet clinical need for a cat‐specific formulation of amlodipine to treat hypertensive cats. OBJECTIVES: To assess the efficacy of chewable amlodipine tablets in reducing systolic blood pressure (SBP) in cats diagnosed with systemic arterial hypertension. ANIMALS: Seventy‐sev...
Autores principales: | Huhtinen, M., Derré, G., Renoldi, H.J., Rinkinen, M., Adler, K., Aspegrén, J., Zemirline, C., Elliott, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895406/ https://www.ncbi.nlm.nih.gov/pubmed/25857394 http://dx.doi.org/10.1111/jvim.12589 |
Ejemplares similares
-
Plasma Renin Activity and Aldosterone Concentrations in Hypertensive Cats with and without Azotemia and in Response to Treatment with Amlodipine Besylate
por: Jepson, R.E., et al.
Publicado: (2013) -
Vaccine‐Associated Leptospira Antibodies in Client‐Owned Dogs
por: Martin, L.E.R., et al.
Publicado: (2014) -
A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA
por: Chappell, Kimberly, et al.
Publicado: (2021) -
Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
por: Visser, Marike, et al.
Publicado: (2022) -
Changes in Systolic Blood Pressure over Time in Healthy Cats and Cats with Chronic Kidney Disease
por: Bijsmans, E.S., et al.
Publicado: (2015)